Pharmacology, Clinical Completed Phase 1 Trials for Levomefolic acid (DB11256)

Also known as: Clinical Pharmacology

IndicationStatusPhase
DBCOND0043229 (Pharmacology, Clinical)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00941057Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium